Elena Suárez

837 total citations
59 papers, 659 citations indexed

About

Elena Suárez is a scholar working on Anesthesiology and Pain Medicine, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Elena Suárez has authored 59 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Anesthesiology and Pain Medicine, 13 papers in Pediatrics, Perinatology and Child Health and 12 papers in Surgery. Recurrent topics in Elena Suárez's work include Anesthesia and Sedative Agents (15 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Drug Transport and Resistance Mechanisms (8 papers). Elena Suárez is often cited by papers focused on Anesthesia and Sedative Agents (15 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Drug Transport and Resistance Mechanisms (8 papers). Elena Suárez collaborates with scholars based in Spain, United States and Greece. Elena Suárez's co-authors include John C. Lukas, R. Calvo, Rosario Calvo, Mónica Rodríguez, C Aguirre, Miren Zamacona, Luciano Aguilera, Valvanera Vozmediano, Estefanía García and Andrés Valdivieso and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and Pharmaceutical Research.

In The Last Decade

Elena Suárez

59 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Suárez Spain 14 161 148 118 98 98 59 659
R. Calvo Spain 14 189 1.2× 88 0.6× 65 0.6× 83 0.8× 88 0.9× 47 538
Rosario Calvo Spain 12 77 0.5× 128 0.9× 100 0.8× 70 0.7× 93 0.9× 30 470
J. C. Levron France 14 157 1.0× 75 0.5× 62 0.5× 70 0.7× 110 1.1× 36 702
T. B. Tjandramaga Belgium 15 74 0.5× 179 1.2× 106 0.9× 66 0.7× 160 1.6× 41 818
Yan Ling Zhang China 14 22 0.1× 70 0.5× 62 0.5× 133 1.4× 59 0.6× 41 544
H Andrew Strong Canada 12 42 0.3× 79 0.5× 95 0.8× 176 1.8× 164 1.7× 18 722
Bernard Vinet Canada 16 44 0.3× 131 0.9× 57 0.5× 97 1.0× 44 0.4× 35 744
James E. Axelson Canada 18 82 0.5× 178 1.2× 96 0.8× 92 0.9× 150 1.5× 65 911
J. Rieder Austria 19 51 0.3× 94 0.6× 82 0.7× 119 1.2× 59 0.6× 43 856
Ann E. Black United Kingdom 19 431 2.7× 61 0.4× 73 0.6× 200 2.0× 53 0.5× 48 1.1k

Countries citing papers authored by Elena Suárez

Since Specialization
Citations

This map shows the geographic impact of Elena Suárez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Suárez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Suárez more than expected).

Fields of papers citing papers by Elena Suárez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Suárez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Suárez. The network helps show where Elena Suárez may publish in the future.

Co-authorship network of co-authors of Elena Suárez

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Suárez. A scholar is included among the top collaborators of Elena Suárez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Suárez. Elena Suárez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lukáčová, Viera, Mónica Rodríguez, Rodrigo Cristofoletti, et al.. (2023). Leveraging Physiologically Based Modelling to Provide Insights on the Absorption of Paliperidone Extended-Release Formulation under Fed and Fasting Conditions. Pharmaceutics. 15(2). 629–629. 1 indexed citations
2.
3.
Rodríguez, Mónica, et al.. (2022). Application of physiologically based absorption and pharmacokinetic modeling in the development process of oral modified release generic products. European Journal of Pharmaceutics and Biopharmaceutics. 176. 87–94. 4 indexed citations
4.
Calvo, Rosario, et al.. (2013). A Predictive Pharmacokinetic/Pharmacodynamic Model of Fentanyl for Analgesia/Sedation in Neonates Based on a Semi-Physiologic Approach. Pediatric Drugs. 15(3). 247–257. 23 indexed citations
5.
Calvo, Rosario, et al.. (2006). The Role of Unbound Drug in Pharmacokinetics/Pharmacodynamics and in Therapy. Current Pharmaceutical Design. 12(8). 977–987. 12 indexed citations
6.
Lukas, John C., Ana Suárez, María Victoria Martínez Calvo, et al.. (2005). Time-dependent pharmacokinetics of cyclosporine (NeoralR) in de novo renal transplant patients. Journal of Clinical Pharmacy and Therapeutics. 30(6). 549–557. 16 indexed citations
7.
Suárez, Elena, Rosario Calvo, Ciriaco Aguirre, et al.. (2005). Bicompartmental kinetics of tobramycin analysed with a wide range of covariates. International Journal of Antimicrobial Agents. 26(4). 304–311. 9 indexed citations
8.
Calvo, R., et al.. (2004). Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients. Acta Anaesthesiologica Scandinavica. 48(8). 1038–1048. 14 indexed citations
9.
Suárez, Elena, Benjamín Paredes, F. Rubiera, et al.. (2002). Functionalized glycidyl methacrylate based polymers as stationary phases for protein retention. Separation and Purification Technology. 27(1). 1–10. 12 indexed citations
10.
Jauregizar, Nerea, Rosario Calvo, Elena Suárez, et al.. (2002). Pharmacokinetics and Pharmacological Effect of Lerisetron, a New 5‐HT3 Antagonist, in Rats. Journal of Pharmaceutical Sciences. 91(1). 41–52. 4 indexed citations
11.
Souich, Patrick du, et al.. (2002). Effect of omeprazole on oral and intravenous RS‐methadone pharmacokinetics and pharmacodynamics in the rat. Journal of Pharmaceutical Sciences. 91(7). 1627–1638. 14 indexed citations
12.
Lukas, John C., et al.. (2002). 'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction. European Journal of Clinical Pharmacology. 58(9). 615–619. 7 indexed citations
13.
Lukas, John C., et al.. (2002). Prediction of Unbound Propofol Concentrations in a Diabetic Population. Therapeutic Drug Monitoring. 24(6). 689–695. 8 indexed citations
14.
Calvo, Rosario, et al.. (1998). Serum protein binding of lerisetron, a novel specific 5HT 3 antagonist, in patients with cancer. Cancer Chemotherapy and Pharmacology. 42(5). 418–422. 7 indexed citations
15.
Zamacona, Miren, Elena Suárez, Estefanía García, C Aguirre, & R. Calvo. (1998). The Significance of Lipoproteins in Serum Binding Variations of Propofol. Anesthesia & Analgesia. 87(5). 1147–1151. 8 indexed citations
16.
Suárez, Elena, et al.. (1995). Altered methadone analgesia due to changes in plasma protein binding: Role of the route of administration. General Pharmacology The Vascular System. 26(6). 1273–1276. 11 indexed citations
17.
Torres, Isabel, et al.. (1995). Differential effect of cancer on the serum protein binding of mianserin and imipramine. European Journal of Drug Metabolism and Pharmacokinetics. 20(2). 107–111. 4 indexed citations
18.
García, Emilio García, et al.. (1995). Resistance to atracurium in rats with experimental inflammation: role of protein binchng. Acta Anaesthesiologica Scandinavica. 39(8). 1019–1023. 13 indexed citations
19.
Valdivieso, Andrés, et al.. (1993). Propranolol Absorption in Peptic Ulcer Disease. Scandinavian Journal of Gastroenterology. 28(7). 643–646. 2 indexed citations
20.
Calvo, R., et al.. (1989). Displacement of warfarin from human serum proteins by halothane anaesthesia. Acta Anaesthesiologica Scandinavica. 33(7). 575–577. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Calvo Breakdown of academic impact, for papers by Rosario Calvo Breakdown of academic impact, for papers by J. C. Levron Breakdown of academic impact, for papers by T. B. Tjandramaga Breakdown of academic impact, for papers by Yan Ling Zhang Breakdown of academic impact, for papers by H Andrew Strong Breakdown of academic impact, for papers by Bernard Vinet Breakdown of academic impact, for papers by James E. Axelson Breakdown of academic impact, for papers by J. Rieder Breakdown of academic impact, for papers by Ann E. Black
Rankless by CCL
2026